235 related articles for article (PubMed ID: 16712455)
21. Anticancer activity of 3-O-acylated betulinic acid derivatives obtained by enzymatic synthesis.
Ahmad FB; Ghaffari Moghaddam M; Basri M; Abdul Rahman MB
Biosci Biotechnol Biochem; 2010; 74(5):1025-9. PubMed ID: 20460723
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and cytotoxic activity of 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivatives.
Bi Y; Xu J; Wu X; Ye W; Yuan S; Zhang L
Bioorg Med Chem Lett; 2007 Mar; 17(5):1475-8. PubMed ID: 17275295
[TBL] [Abstract][Full Text] [Related]
23. Understanding the structure-activity relationship of betulinic acid derivatives as anti-HIV-1 agents by using 3D-QSAR and docking.
Lan P; Chen WN; Huang ZJ; Sun PH; Chen WM
J Mol Model; 2011 Jul; 17(7):1643-59. PubMed ID: 20978914
[TBL] [Abstract][Full Text] [Related]
24. A Review on Preparation of Betulinic Acid and Its Biological Activities.
Lou H; Li H; Zhang S; Lu H; Chen Q
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577056
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic heterocyclic triterpenoids derived from betulin and betulinic acid.
Urban M; Vlk M; Dzubak P; Hajduch M; Sarek J
Bioorg Med Chem; 2012 Jun; 20(11):3666-74. PubMed ID: 22551630
[TBL] [Abstract][Full Text] [Related]
26. Betulinic acid and its derivatives as anti-angiogenic agents.
Mukherjee R; Jaggi M; Rajendran P; Siddiqui MJ; Srivastava SK; Vardhan A; Burman AC
Bioorg Med Chem Lett; 2004 May; 14(9):2181-4. PubMed ID: 15081004
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of A-seco derivatives of betulinic acid with cytotoxic activity.
Urban M; Sarek J; Klinot J; Korinkova G; Hajduch M
J Nat Prod; 2004 Jul; 67(7):1100-5. PubMed ID: 15270560
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, characterization and augmented anticancer potential of PEG-betulinic acid conjugate.
Saneja A; Sharma L; Dubey RD; Mintoo MJ; Singh A; Kumar A; Sangwan PL; Tasaduq SA; Singh G; Mondhe DM; Gupta PN
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():616-626. PubMed ID: 28183653
[TBL] [Abstract][Full Text] [Related]
29. Novel semisynthetic analogues of betulinic acid with diverse cytoprotective, antiproliferative, and proapoptotic activities.
Liby K; Honda T; Williams CR; Risingsong R; Royce DB; Suh N; Dinkova-Kostova AT; Stephenson KK; Talalay P; Sundararajan C; Gribble GW; Sporn MB
Mol Cancer Ther; 2007 Jul; 6(7):2113-9. PubMed ID: 17620440
[TBL] [Abstract][Full Text] [Related]
30. [Synthesis and antiviral activity of hydrazides and substituted benzalhydrazides of betulinic acid and its derivatives].
Flekhter OB; Boreko EI; Nigmatullina LR; Pavlova NI; Nikolaeva SN; Savinova OV; Eremin VF; Baltina LA; Galin FZ; Tolstikov GA
Bioorg Khim; 2003; 29(3):326-32. PubMed ID: 12845810
[TBL] [Abstract][Full Text] [Related]
31. The design, synthesis and structure-activity relationships associated with C28 amine-based betulinic acid derivatives as inhibitors of HIV-1 maturation.
Chen Y; Sit SY; Chen J; Swidorski JJ; Liu Z; Sin N; Venables BL; Parker DD; Nowicka-Sans B; Lin Z; Li Z; Terry BJ; Protack T; Rahematpura S; Hanumegowda U; Jenkins S; Krystal M; Dicker ID; Meanwell NA; Regueiro-Ren A
Bioorg Med Chem Lett; 2018 May; 28(9):1550-1557. PubMed ID: 29631960
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and anti-HIV activity of 3-alkylamido-3-deoxy-betulinic acid derivatives.
Kashiwada Y; Chiyo J; Ikeshiro Y; Nagao T; Okabe H; Cosentino LM; Fowke K; Morris-Natschke SL; Lee KH
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1387-90. PubMed ID: 10993248
[TBL] [Abstract][Full Text] [Related]
33. Betulin-betulinic acid natural product based analogs as anti-cancer agents.
Jonnalagadda SC; Corsello MA; Sleet CE
Anticancer Agents Med Chem; 2013 Dec; 13(10):1477-99. PubMed ID: 23848199
[TBL] [Abstract][Full Text] [Related]
34. Anti-AIDS agents 81. Design, synthesis, and structure-activity relationship study of betulinic acid and moronic acid derivatives as potent HIV maturation inhibitors.
Qian K; Kuo RY; Chen CH; Huang L; Morris-Natschke SL; Lee KH
J Med Chem; 2010 Apr; 53(8):3133-41. PubMed ID: 20329730
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of 3-O-propargylated betulinic acid and its 1,2,3-triazoles as potential apoptotic agents.
Majeed R; Sangwan PL; Chinthakindi PK; Khan I; Dangroo NA; Thota N; Hamid A; Sharma PR; Saxena AK; Koul S
Eur J Med Chem; 2013 May; 63():782-92. PubMed ID: 23584541
[TBL] [Abstract][Full Text] [Related]
36. Betulinic acid as apoptosis activator: Molecular mechanisms, mathematical modeling and chemical modifications.
Kumar P; Bhadauria AS; Singh AK; Saha S
Life Sci; 2018 Sep; 209():24-33. PubMed ID: 30076920
[TBL] [Abstract][Full Text] [Related]
37. Triphenylphosphonium Analogues of Betulin and Betulinic Acid with Biological Activity: A Comprehensive Review.
Grymel M; Zawojak M; Adamek J
J Nat Prod; 2019 Jun; 82(6):1719-1730. PubMed ID: 31141361
[TBL] [Abstract][Full Text] [Related]
38. Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line.
Liu WK; Ho JC; Cheung FW; Liu BP; Ye WC; Che CT
Eur J Pharmacol; 2004 Sep; 498(1-3):71-8. PubMed ID: 15363977
[TBL] [Abstract][Full Text] [Related]
39. Design, semisynthesis and cytotoxic activity of novel ester derivatives of betulinic acid-1,2,4 oxadiazoles.
Challa K; Bhargavi MV; Krupadanam GL
J Asian Nat Prod Res; 2016 Dec; 18(12):1158-1168. PubMed ID: 27314626
[TBL] [Abstract][Full Text] [Related]
40. In vitro anticancer activity of Betulinic acid and derivatives thereof on equine melanoma cell lines from grey horses and in vivo safety assessment of the compound NVX-207 in two horses.
Liebscher G; Vanchangiri K; Mueller T; Feige K; Cavalleri JM; Paschke R
Chem Biol Interact; 2016 Feb; 246():20-9. PubMed ID: 26772157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
